⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 19, 2024Pediatric Transplantation

Initiation of Haploidentical Stem Cell Transplantation With Post‐Transplant Cyclophosphamide in Children: A Low–Middle‐Income Country Institutional Experience

Syed Ibrahim Bukhari Javeria Saeed Zehra Fadoo Asim Belgaumi Naureen Allani Sadaf Altaf

View at Publisher

Ask AI

Bookmark

Share

Abstract

Haploidentical hematopoietic stem cell transplant (HSCT) is a curative treatment especially for countries where bone marrow registries are nonexistent. We present our experience with haploidentical HSCT in pediatric patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bukhari et al. (2024) studied this question.

synapsesocial.com/papers/68e5bc32b6db643587554282 https://doi.org/10.1111/petr.14842

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders2024 · 14 citations
2Real-World Challenges of Haplo-Identical Hematopoietic Stem Cell Transplant in a Developing Country: A Single Center Experience2024 · 1 citations
3Haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide in the public Chilean national health system: A single center studyOriginal Research · 2025
4Expanding access in pediatrics: Outcomes of haploidentical transplantation with reduced intensity and peripheral blood stem cells2025
5Haploidentical transplantation in high‐risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH)Retrospective Study · 2019 · 46 citations

More related papers

Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience2024
Excellent Outcomes of Hematopoietic Stem Cell Transplant for Pediatric High Risk and Relapsed Acute Myeloid Leukemia–A Decade Long Experience From Developing Nation2025
Combination of post-transplant cyclophosphamide and anti-thymocyte globulin for haploidentical stem cell transplantation in pediatric patients with acute leukemia2026

More from Pediatric Transplantation

Improving Access to Transplant: A Quality Improvement Initiative to Reduce Time From Outpatient Dialysis Initiation to Deceased Donor Kidney Transplant ActivationThu,
Vampire Problems in Pediatric Kidney Transplantation‐Navigating Transformative Experiences and Informed ConsentWed,